Blis Technologies forecasts annual loss even as revenue doubles

Blis Technologies forecasts annual loss even as revenue doubles
Sophie Boot
By Sophie Boot Feb. 29 (BusinessDesk) - Blis Technologies, the NZX-listed biotech company, expects to post a loss for the year even as revenue more than doubles after it was hit by costs from having to replace stock that had discoloured. The Dunedin-based company is anticipating a small deficit in earnings before interest, tax, depreciation and amortisation in the year ending March 31, 2016, while sales are expected to increase to more than $5.3 million from $2.5 million a year earlier, it said in a statement. The priobiotics manufacturer...